NASDAQ:BNGO
BioNano Genomics Stock News
$0.95
+0.0007 (+0.0737%)
At Close: May 03, 2024
Three Top European Sites Adopt Bionano Saphyr® for Cancer, Genetics, and Cytogenetic Applications
12:00pm, Monday, 23'rd Mar 2020
Bionano Genomics, Inc. (BNGO) announced today that the following top European institutions have recently incorporated the Saphyr® system into their repertoire of solutions for genome analysis and are
The Daily Biotech Pulse: Pfizer's Eczema Drug Aces Latestage Study, Orphan Drug Designation For Dicerna, Dyadic's COVID-19 Connection
12:00am, Thursday, 19'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week highs on March 18)
Biomerica, Inc. (NASDAQ...
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks that hit 52-week highs March 12.)
Masimo...
Bionano Genomics Will Be Used in Research Identifying Gene Variants that Contribute to Coronavirus Disease Susceptibility
12:00pm, Tuesday, 10'th Mar 2020
Bionano Genomics announced the launch of a global network of studies aiming to identify genomic variants that influence COVID-19 disease resistance, sensitivity, disease progression and drug response.
CY, VALE among premarket losers
02:17pm, Friday, 06'th Mar 2020
TransEnterix (NYSEMKT:TRXC) -57% after pricing equity offering.American Outdoor Brands (NASDAQ:AOBC) -26% as coronavirus impact weighs and Q4 earnings.Bionano Genomics (NASDAQ:BNGO) -23% on Q4 e
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit hit 52-week highs March 5.) * Arcus Biosciences Inc (NYSE: RCUS) * Arcturu
7 Stocks Moving In Thursday's After-Hours Session
10:22pm, Thursday, 05'th Mar 2020
Gainers
Okta (NASDAQ: OKTA) shares are trading higher after the company reported better-than-expected Q4 EPS and sales results. The company issued Q1 and FY21 sales guidance...
Bionano Genomics Reports Fourth Quarter and Year End 2019 Financial Results and Provides Business Update
09:01pm, Thursday, 05'th Mar 2020
SAN DIEGO, March 05, 2020 -- Bionano Genomics, Inc. (NASDAQ: BNGO), a life sciences instrumentation company that develops and markets Saphyr®, a platform for ultra-sensitive.
The Daily Biotech Pulse: Trevana Pain Drug Resubmission Accepted For Review, Can-Fite To Explore Treatment For COVID-19
01:05pm, Thursday, 05'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 4) * 89bio Inc (NASDAQ: ETNB) * Arcus Biosciences In
Healthcare dominates premarket losers amidst coronavirus situation
02:23pm, Tuesday, 03'rd Mar 2020
Spherix (NASDAQ:SPEX) -25%.Dynatronics (NASDAQ:DYNT) -22%.China Pharma Holdings (NYSEMKT:CPHI) -19%.Co-Diagnostics (NASDAQ:CODX) -17%.Tilray (NASDAQ:TLRY) -14% on Q4 earnings.Cleveland BioLabs (NAS
Bionano Genomics to Report Fourth Quarter and Year End 2019 Financial Results and Host a Conference Call and Webcast on March 5
09:01pm, Friday, 28'th Feb 2020
SAN DIEGO, Feb. 28, 2020 -- Bionano Genomics, Inc. (NASDAQ: BNGO), a life sciences instrumentation company that develops and markets Saphyr®, a platform for ultra-sensitive and.
Bionano Genomics (BNGO) today announced updates to the Saphyr® System designed to increase the speed of data collection, simplify sample preparation for solid tumors and animal tissue and significant
Bionano Genomics Data Drives Scientific Discoveries in Solid Tumors and Leukemias, To Be Presented at the 2020 AGBT Conference
01:00pm, Friday, 21'st Feb 2020
Bionano Genomics, Inc. (BNGO), a life sciences instrumentation company that develops and markets Saphyr®, a platform for ultra-sensitive and ultra-specific structural variation detection in genome an
TSLA, INO among premarket gainers
02:16pm, Monday, 10'th Feb 2020
vTv Therapeutics (NASDAQ:VTVT) +80% on positive TTP399 data.Taubman Centers (NYSE:TCO) +52% on being acquired by Simon Property Group.Edgewell Personal Care (NYSE:EPC) +21% after Q4 results.Mereo B
Bionano Genome Imaging Concordant with Traditional Cytogenetics in Landmark Leukemia Study
01:00pm, Monday, 10'th Feb 2020
Bionano Genomics, Inc. (BNGO) announced today that a team led by Dr. Alexander Hoischen from Radboud University Medical Center (RUMC) in the Netherlands reported the results of a successful validation
